{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:29Z","timestamp":1790740229710,"version":"4.1.0"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["102-2320-B-002-041-MY2"],"award-info":[{"award-number":["102-2320-B-002-041-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["104-2320-B-002-063-MY3"],"award-info":[{"award-number":["104-2320-B-002-063-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["106-2923-B-002-001-MY3"],"award-info":[{"award-number":["106-2923-B-002-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content content-type=\"genus-species\">Candida glabrata<\/jats:named-content>\n            , the second most frequent cause of candidiasis after\n            <jats:named-content content-type=\"genus-species\">Candida albicans<\/jats:named-content>\n            , is an emerging human fungal pathogen that is intrinsically drug tolerant. Currently, studies of\n            <jats:named-content content-type=\"genus-species\">C. glabrata<\/jats:named-content>\n            genes involved in drug tolerance are limited. Ada2, a component serving as a transcription adaptor of the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex, is required for antifungal drug tolerance and virulence in\n            <jats:named-content content-type=\"genus-species\">C. albicans<\/jats:named-content>\n            . However, its roles in\n            <jats:named-content content-type=\"genus-species\">C. glabrata<\/jats:named-content>\n            remain elusive. In this study, we found that\n            <jats:italic>ada2<\/jats:italic>\n            mutants demonstrated severe growth defects at 40\u00b0C but only mild defects at 37\u00b0C or 25\u00b0C. In addition,\n            <jats:italic>C. glabrata ada2<\/jats:italic>\n            mutants exhibited pleiotropic phenotypes, including susceptibility to three classes of antifungal drugs (i.e., azoles, echinocandins, and polyenes) and cell wall-perturbing agents but resistance to the endoplasmic reticulum stressor tunicamycin. According to RNA sequence analysis, the expression of 43 genes was downregulated and the expression of 442 genes was upregulated in the\n            <jats:italic>ada2<\/jats:italic>\n            mutant compared to their expression in the wild type.\n            <jats:italic>C. glabrata ADA2<\/jats:italic>\n            , along with its downstream target\n            <jats:italic>ERG6<\/jats:italic>\n            , controls antifungal drug tolerance and cell wall integrity. Surprisingly,\n            <jats:italic>ada2<\/jats:italic>\n            mutants were hypervirulent in a murine model of systemic infection, possibly due to the upregulation of multiple adhesin-like genes, increased agar invasion, and overstimulation of murine tumor necrosis factor alpha production.\n          <\/jats:p>","DOI":"10.1128\/aac.01924-17","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T20:33:50Z","timestamp":1515184430000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":43,"title":["Deletion of\n            <i>ADA2<\/i>\n            Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata"],"prefix":"10.1128","volume":"62","author":[{"given":"Shang-Jie","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lin","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-470X","authenticated-orcid":false,"given":"Ying-Lien","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.06.012"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12539"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-06"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2009.03.007"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(01)02094-7"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780701435317"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.06.034"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5427.578"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1567-1364.2011.00785.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12091"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.9.3529-3538.1997"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/314546"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116974"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611195104"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.3.2.546-552.2004"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004478"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01271-10"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.478743"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.1.519"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/35015104"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110849200"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90100-Q"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.09.088"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.108.092932"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020021"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E08-11-1093"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00163-09"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002411"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00184-07"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.13528"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx028"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019752"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbr.2014.07.001"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00284-08"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.13.10.5981"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw324"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003160"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1567-1364.2010.00611.x"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1534\/g3.112.002279"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03065-14"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/340511"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12686"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01223-07"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2005.06.012"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04465.x"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02579"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.06.021"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.6.1425"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(81)90281-5"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00302-13"},{"key":"e_1_3_3_53_2","volume-title":"Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline M44-A2","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute. 2009. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline M44-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_54_2","volume-title":"Document M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference methods for broth dilution antifungal susceptibility testing of yeasts: approved standard, 2nd ed. Document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01924-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01924-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:06:40Z","timestamp":1645477600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01924-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1128\/AAC.01924-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.01924-17","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"2017-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01924-17"}}